[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 2, 2004, Pages 196-201

  Kim, Sungeun ^a   Chung, June Key ^a   Kang, Soon Beom ^a   Kim, Moon Hong ^a   Jeong, Jae Min ^a   Lee, Dong Soo ^a   Lee, Myung Chul ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

FDG PET; Ovarian carcinoma; Second look laparotomy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; ANALGESIC AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LAPAROTOMY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; SECOND LOOK SURGERY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; KOREA; METHODOLOGY; MIDDLE AGED; MORTALITY; OVARY TUMOR; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANALGESICS; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; KOREA; LAPAROTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SECOND-LOOK SURGERY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0842269090     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1367-y     Document Type: Article

References (21)

1. Megibow AJ, Bosniak MA, Ho AG, Beller U, Hulnick DH, Beckman EM. Accuracy of CT in detection of persistent of recurrent ovarian carcinoma: correlation with second-look laparotomy. Radiology 1988; 166:341-345.
2. Rubin SC, Randall TC, Armstrong KA, Chi DS, Hoskins WJ. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol 1999; 93:21-24.
3. Rubinstein E, Knudsen JB. Clinical aspects of second-look laparotomy in ovarian cancer. Ann Chir Gynecol. 1986; 75:177-179.
4. Podratz KC, Kinney WK. Second-look operation in ovarian cancer. Cancer 1993; 71:1551-1558.
5. Baram A, Kovner F, Lessing JB, et al. A second though on second look laparotomy. Acta Obstet Gynecol Scand. 1993; 72:386-390.
6. Obermair A, Sevelda P. Impact of second look laparotomy and secondary cytoreductive surgery in ovarian cancer patients. Acta Obstet Gynecol Scand 2001; 80:432-436.
7. Sijmons EA, Heintz AP. Second-look and second surgery: second chance or second best? Semin Surg Oncol 2000; 19:54-61.
8. Cho SM, Ha HK, Byun JY, et al. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR 2002; 179:391-395.
9. Wang PH, Liu RS, Li YF, Ng HT, Yuan CC. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: an initial report. Gynecol Oncol 2000; 77:44-47.
10. Torizuka T, Nobezawa S, Kanno T, et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose. Eur J Nucl Med Mol Imaging 2002; 29:797-803.
11. Zimny M, Siggelkow W, Schroder W, et al. 2-[Fluorine-18]-fluoro-2-deoxy -D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001; 83:310-315.
12. Yuan CC, Liu RS, Wang PH, Ng HT, Yeh SH. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report. J Reprod Med 1999; 44:775-778.
13. Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001; 39:883-917.
14. Nakamoto Y, Eisbruch A, Achtyes ED, et al. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 2002; 84:289-295.
15. Rose PG, Faulhaber P, Miraldi F, Abdul-Karim FW. Positron emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 2001; 82:17-21.
16. 18F-FDG PET) in diagnosis of ovarian cancer. Int J Gynecol Cancer 1999;9:117-122.
17. Casey MJ, Gupta NC, Muths CK. Experience with positron emission tomography (PET) scans in patients with ovarian cancer. Gynecol Oncol 1994; 53:331-338.
18. Nakamoto Y, Saga T, Ishimori T, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR 2001; 176:1449-1454.
19. Gershenson DM, Copeland LJ, Wharton JT, et al. Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer. 1985; 55:1129-1135.
20. de Gramont A, Drolet Y, Varette C, et al. Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients. Eur J Cancer Clin Oncol 1989; 25:451-457.
21. Luesley DM, Chan KK, Lawton FG, Blackledge GR, Mould JM. Survival after negative second-look laparotomy. Eur J Surg Oncol 1989; 15:205-210.